Driehaus Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Driehaus Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-523,060	Closed	-$14.1M	–	676
2017 Q1	$14.1M	Buy	523,060 +73,353	+16%	+$1.5M	0.48%	42
2016 Q4	$8.55M	Sell	449,707 -358,678	-44%	-$6.85M	0.3%	70
2016 Q3	$15.8M	Sell	808,385 -82,889	-9%	-$1.4M	0.53%	38
2016 Q2	$13.3M	Buy	891,274 +120,872	+16%	+$1.52M	0.48%	42
2016 Q1	$7.09M	Sell	770,402 -33,324	-4%	-$404K	0.23%	80
2015 Q4	$15.5M	Buy	803,726 +20,355	+3%	+$353K	0.52%	41
2015 Q3	$11.6M	Buy	+783,371	New	+$18.4M	0.42%	58

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Driehaus Capital Management's FLXN Position: Q2 2017 in Review

Driehaus Capital Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2017, closing a stake of 523,060 shares — an estimated $14.1M sold.

Driehaus Capital Management first reported a position in FLXN in Q3 2015 and held it in 7 quarters. The position peaked at $15.8M in Q3 2016. 100 funds tracked by Wall St. Rank hold FLXN as of Q2 2017.

Driehaus Capital Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
Driehaus Capital Management sold 523,060 Flexion Therapeutics, Inc. shares in Q2 2017, an estimated $14.1M.
Driehaus Capital Management first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 7 quarters.
Driehaus Capital Management's Flexion Therapeutics, Inc. position peaked at $15.8M in Q3 2016.
100 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2017.

Based on Driehaus Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.